Tibet Duo Rui Pharmaceutical: CITIC Securities Co., Ltd.'s 2023 follow-up report on Tibet Dorui Pharmaceutical Co., Ltd.
Tibet Duo Rui Pharmaceutical: CITIC Securities Co., Ltd. report on the 2023 continuous supervision and regular on-site inspection report of Tibet Dorui Pharmaceutical Co., Ltd.
Tibet Duo Rui Pharmaceutical: CITIC Securities Co., Ltd. on the inspection results of Tibet Dorui Pharmaceutical Co., Ltd.'s 2023 continuous supervision work site inspection results and reminders to the company
Tibet Duo Rui Pharmaceutical: Progress announcement on the use of temporarily idle funds raised for cash management due and redemption
Tibet Duo Rui Pharmaceutical: 2024/04/25 Investor Relations Activity Schedule
Dorui Pharmaceuticals: Announcement of Resolutions of the 12th Meeting of the 2nd Board of Supervisors
Dorui Pharmaceuticals: Announcement of Resolutions of the 12th Meeting of the 2nd Board of Directors
Dorui Pharmaceuticals: Entrusted Financial Management System
Dorui Pharmaceuticals: Supervisory Board Opinions on Matters Related to the 12th Meeting of the 2nd Board of Supervisors
Dorui Pharmaceuticals: Management System for the Submission and Use of External Information
Dorui Pharmaceuticals: Announcement on holding the 2023 Online Results Briefing
Dorui Pharmaceuticals: The Board\'s Special Opinion on the Independent Director\'s Assessment
Dorui Pharmaceuticals: Annual Storage and Use Verification Report of Raised Funds
Dorui Pharmaceuticals: Supervisory Board Opinions on Matters Related to the 11th Meeting of the 2nd Board of Supervisors
Dorui Pharmaceuticals: Articles of Association
Dorui Pharmaceutical: CITIC Securities Co., Ltd.'s special inspection opinion on the storage and use of funds raised by Tibet Dorui Pharmaceutical Co., Ltd. in 2023
Dorui Pharmaceuticals: Special Audit Instructions for 2023 Dorui Pharmaceutical\'s Non-Operating Capital Occupation and Other Related Fund Transactions
Dorui Pharmaceuticals: Announcement on the confirmation of daily related transactions in 2023
Dorui Pharmaceuticals: Independent Director\'s 2023 Debriefing Report (Liu Yingfei)
Dorui Pharmaceutical: CITIC Securities Co., Ltd.\'s inspection opinion on the confirmation of daily related transactions of Tibet Dorui Pharmaceutical Co., Ltd. in 2023
No Data